title: Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain.
abstract: Although a number of studies have examined amyloid precursor protein (APP) mRNA levels in Alzheimer's disease (AD), no clear consensus has emerged as to whether the levels of transcripts for isoforms containing a Kunitz protease inhibitory (KPI)-encoded region are increased or decreased in AD. Here we compare AD and control brain for the relative amounts of APP protein containing KPI to APP protein lacking this domain. APP protein was purified from the soluble subcellular fraction and Triton X-100 membrane pellet extract of one hemisphere of AD (n = 10), normal (n = 7), and neurological control (n = 5) brains. The amount of KPI-containing APP in the purified protein samples was determined using two independent assay methods. The first assay exploited the inhibitory action of KPI-containing APP on trypsin. The second assay employed reflectance analysis of Western blots. The proportion of KPI-containing forms of APP in the soluble subcellular fraction of AD brains is significantly elevated (p < 0.01) compared with controls. Species containing a KPI domain comprise 32-41 and 76-77% of purified soluble APP from control and AD brains, respectively. For purified membrane-associated APP, 72-77 and 65-82% of control and AD samples, respectively, contain a KPI domain. Since KPI-containing species of APP may be more amyloidogenic (Ho, L., Fukuchi, K., and Yonkin, S. G. (1996) J. Biol. Chem. 271, 30929-30934), our findings support an imbalance of isoforms as one possible mechanism for amyloid deposition in sporadic AD.
authors.affiliation: Department of Pathology, The University of Melbourne, Parkville, 3052, Australia and The Mental Health Research Institute of Victoria, Parkville 3052, Australia.
authors.forename: R D
authors.initials: RD
authors.lastname: Moir
authors.forename: T
authors.initials: T
authors.lastname: Lynch
authors.forename: A I
authors.initials: AI
authors.lastname: Bush
authors.forename: S
authors.initials: S
authors.lastname: Whyte
authors.forename: A
authors.initials: A
authors.lastname: Henry
authors.forename: S
authors.initials: S
authors.lastname: Portbury
authors.forename: G
authors.initials: G
authors.lastname: Multhaup
authors.forename: D H
authors.initials: DH
authors.lastname: Small
authors.forename: R E
authors.initials: RE
authors.lastname: Tanzi
authors.forename: K
authors.initials: K
authors.lastname: Beyreuther
authors.forename: C L
authors.initials: CL
authors.lastname: Masters
mesh_terms: D017398:Alternative Splicing; D000544:Alzheimer Disease / Q000235:genetics; D016564:Amyloid beta-Protein Precursor / Q000235:genetics / Q000302:isolation & purification*; D007611:Aprotinin / Q000235:genetics / Q000302:isolation & purification*; D001923:Brain Chemistry / Q000235:genetics; D006801:Humans; D011499:Protein Processing, Post-Translational; D013347:Subcellular Fractions / Q000737:chemistry; D014361:Trypsin Inhibitors / Q000235:genetics / Q000302:isolation & purification*
chemical_list: D016564:Amyloid beta-Protein Precursor; D014361:Trypsin Inhibitors; D007611:Aprotinin